27 insiders have filed at ABBV since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Gonzalez Richard A | Director | 386.5k | 0.022% | 7 sells $118.4M | |
| Saleki-Gerhardt Azita | EVP, Chief Operations Officer | 204.4k | 0.012% | 2 sells $17.6M | |
| Michael Robert A. | Chairman Of The Board And CEO | 178.7k | 0.01% | 2 sells $12.2M | |
| Freyman Thomas C | Director | 132.7k | <0.01% | ||
| Hudson Thomas J | SVP, Cso, Global Research | 107.3k | <0.01% | ||
| Stewart Jeffrey Ryan | EVP, Chief Commercial Officer | 84.5k | <0.01% | 5 sells $22.9M | |
| Donoghoe Nicholas | EVP, Chief Bus/Strat Officer | 74.4k | <0.01% | 4 sells $6.8M | |
| Thakkar Roopal | EVP, R&d And Cso | 55.4k | <0.01% | ||
| Tilton Glenn F | Director | 51.9k | <0.01% | ||
| Rapp Edward J | Director | 44.8k | <0.01% | ||
| Reents Scott T | EVP, Chief Financial Officer | 38.8k | <0.01% | 2 sells $6.3M | |
| Austin Roxanne S | Director | 38.5k | <0.01% | ||
| Alpern Robert J | Director | 35.6k | <0.01% | ||
| Waddell Frederick H | Director | 29.0k | <0.01% | ||
| Burnside William H.L. | Director | 27.0k | <0.01% | ||
| Hart Brett J | Director | 19.5k | <0.01% | ||
| Meyer Melody B | Director | 16.5k | <0.01% | ||
| Roberts Rebecca B | Director | 13.7k | <0.01% | ||
| Crum Demetris D | EVP, Chief Hr Officer | 7.9k | <0.01% | ||
| Buckbee Kevin K | SVP, Controller | 7.8k | <0.01% | 4 sells $5.1M | |
| Abbvie Inc. | EVP, Chief Hr Officer | 7.0k | <0.01% | ||
| Richmond Timothy J. | EVP, Chief Hr Officer | 6.1k | <0.01% | 13 sells $24.0M | |
| Siatis Perry C | EVP, Gc And Secretary | 4.6k | <0.01% | 13 sells $20.7M | |
| Falk Thomas J | Director | 4.2k | <0.01% | ||
| Purdue David Ryan | SVP, Controller | 2.7k | <0.01% | 1 sells $1.2M | |
| Davis Jennifer L. | Director | 2.5k | <0.01% | ||
| Quaggin Susan E | Director | 2.5k | <0.01% |
Full register at boothcheck.com/insiders/ABBV. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.